Results 31 to 40 of about 158,510 (246)

Fibrinolytic abnormalities in acute respiratory distress syndrome (ARDS) and versatility of thrombolytic drugs to treat COVID‐19

Journal of Thrombosis and Haemostasis, 2020
The global pandemic of coronavirus disease 2019 (COVID‐19) is associated with the development of acute respiratory distress syndrome (ARDS), which requires ventilation in critically ill patients.
C. Whyte, G. Morrow, Joanne L. Mitchell, P. Chowdary, N. Mutch   +4 more
semanticscholar   +1 more source

Neutrophil Extracellular Traps Augmented Alveolar Macrophage Pyroptosis via AIM2 Inflammasome Activation in LPS-Induced ALI/ARDS

Journal of Inflammation Research, 2021
Background Uncontrollable inflammation is a critical feature of gram-negative bacterial pneumonia-induced acute respiratory distress syndrome (ARDS).
Haitao Li, Yi Li, Chao Song, Yongbin Hu, Minhui Dai, Ben Liu, P. Pan   +6 more
semanticscholar   +1 more source

Control of respiratory drive by extracorporeal CO2 removal in acute exacerbation of COPD breathing on non-invasive NAVA

Critical Care, 2019
Background Veno-venous extracorporeal CO2 removal (vv-ECCO2R) and non-invasive neurally adjusted ventilator assist (NIV-NAVA) are two promising techniques which may prevent complications related to prolonged invasive mechanical ventilation in patients ...
Christian Karagiannidis, Stephan Strassmann, Sarah Schwarz, Michaela Merten, Eddy Fan, Jennifer Beck, Christer Sinderby, Wolfram Windisch   +7 more
doaj   +1 more source

Factors determining ARDS and mortality in Covid-19 pneumonia

Journal of Contemporary Medicine, 2021
Introduction COVID-19 is caused by a newly discovered corona virus called severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). COVID-19 patients often present with fever, myalgia or fatigue and dry cough.
Saylav Bora, Adnan Yamanoğlu, Nalan Gökçe Çelebi Yamanoğlu, Cüneyt Arıkan, Hüseyin Acar   +4 more
doaj   +1 more source

ECMO for severe ARDS: systematic review and individual patient data meta-analysis

Intensive Care Medicine, 2020
To assess the effect of venovenous extracorporeal membrane oxygenation (ECMO) compared to conventional management in patients with severe acute respiratory distress syndrome (ARDS).
A. Combes, G. Peek, D. Hajage, P. Hardy, D. Abrams, M. Schmidt, A. Dechartres, D. Elbourne   +7 more
semanticscholar   +1 more source

COVID-19-related Secondary Bacterial Infections in Intubated Critical Illness

Cam & Sakura Medical Journal, 2023
Objective: The prevalence, occurrence, and characteristics of bacterial infection in individuals with severe acute respiratory syndrome coronavirus-2 is primarily unknown. In this research, we examined the effects of secondary bacterial infections (SBI),
Derya Tatlısuluoğlu, Gülçin Hilal Alay, Onur Özalp, Güldem Turan   +3 more
doaj   +1 more source

Impact of membrane lung surface area and blood flow on extracorporeal CO2 removal during severe respiratory acidosis

Intensive Care Medicine Experimental, 2017
Background Veno-venous extracorporeal CO2 removal (vv-ECCO2R) is increasingly being used in the setting of acute respiratory failure. Blood flow rates through the device range from 200 ml/min to more than 1500 ml/min, and the membrane surface areas range
Christian Karagiannidis, Stephan Strassmann, Daniel Brodie, Philine Ritter, Anders Larsson, Ralf Borchardt, Wolfram Windisch   +6 more
doaj   +1 more source

Association of gut microbiota in the pathogenesis of acute respiratory distress syndrome and possible pharmacotherapy by sphingosine-1-phosphate

Journal of Advanced Biotechnology and Experimental Therapeutics, 2023
The Acute Respiratory Distress Syndrome (ARDS) is one of the major heterogeneous clinical manifestations of severe respiratory failure developing in response to pathogenetic mechanisms and several inflammatory insults. The translocation of gut microbiota
Tasbir Amin, Fahd Bin Zahed
doaj   +1 more source

Major bleeding after pronation in severe COVID-19 patient [PDF]

Journal of Research in Clinical Medicine, 2021
Contrarily to SARS and MERS, the evidence suggests that thromboembolic events are common in patients with COVID-19 pneumonia. The clinical course of severe COVID-19 patients can be complicated with coagulopathy, causing fatal thromboembolic events and ...
Rosanna Carmela De Rosa, Michele Gallifuoco, Antonio Romanelli, Antonio Corcione   +3 more
doaj   +1 more source

The Characteristics of 50 Hospitalized COVID-19 Patients With and Without ARDS.

Deutsches Ärzteblatt International, 2020
BACKGROUND The type of pneumonia (coronavirus disease 2019, COVID-19) that is caused by the new coronavirus (severe acute respiratory syndrome coronavirus 2, SARS-CoV-2) is now spreading across the world in a pandemic.
M. Dreher, A. Kersten, J. Bickenbach, Paul Balfanz, Bojan Hartmann, C. Cornelissen, Ayham Daher, R. Stöhr, M. Kleines, S. Lemmen, J. Brokmann, Tobias Müller, D. Müller-Wieland, G. Marx, N. Marx   +14 more
semanticscholar   +1 more source